BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 32013265)

  • 1. miR-20b and miR-451a Are Involved in Gastric Carcinogenesis through the PI3K/AKT/mTOR Signaling Pathway: Data from Gastric Cancer Patients, Cell Lines and Ins-Gas Mouse Model.
    Streleckiene G; Inciuraite R; Juzenas S; Salteniene V; Steponaitiene R; Gyvyte U; Kiudelis G; Leja M; Ruzgys P; Satkauskas S; Kupcinskiene E; Franke S; Thon C; Link A; Kupcinskas J; Skieceviciene J
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32013265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-101-2, miR-125b-2 and miR-451a act as potential tumor suppressors in gastric cancer through regulation of the PI3K/AKT/mTOR pathway.
    Riquelme I; Tapia O; Leal P; Sandoval A; Varga MG; Letelier P; Buchegger K; Bizama C; Espinoza JA; Peek RM; Araya JC; Roa JC
    Cell Oncol (Dordr); 2016 Feb; 39(1):23-33. PubMed ID: 26458815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The GAS5/miR-222 Axis Regulates Proliferation of Gastric Cancer Cells Through the PTEN/Akt/mTOR Pathway.
    Li Y; Gu J; Lu H
    Dig Dis Sci; 2017 Dec; 62(12):3426-3437. PubMed ID: 29098549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-183 affects the development of gastric cancer by regulating autophagy via MALAT1-miR-183-SIRT1 axis and PI3K/AKT/mTOR signals.
    Li H; He C; Wang X; Wang H; Nan G; Fang L
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3163-3171. PubMed ID: 31352788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs and the PTEN/PI3K/Akt pathway in gastric cancer (Review).
    Hu M; Zhu S; Xiong S; Xue X; Zhou X
    Oncol Rep; 2019 Mar; 41(3):1439-1454. PubMed ID: 30628706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor suppressive activity of miR-424-5p in breast cancer cells through targeting PD-L1 and modulating PTEN/PI3K/AKT/mTOR signaling pathway.
    Dastmalchi N; Hosseinpourfeizi MA; Khojasteh SMB; Baradaran B; Safaralizadeh R
    Life Sci; 2020 Oct; 259():118239. PubMed ID: 32784058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-17 targets PTEN and facilitates glial scar formation after spinal cord injuries via the PI3K/Akt/mTOR pathway.
    Luan Y; Chen M; Zhou L
    Brain Res Bull; 2017 Jan; 128():68-75. PubMed ID: 27693649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-592 Promotes Gastric Cancer Proliferation, Migration, and Invasion Through the PI3K/AKT and MAPK/ERK Signaling Pathways by Targeting Spry2.
    He Y; Ge Y; Jiang M; Zhou J; Luo D; Fan H; Shi L; Lin L; Yang L
    Cell Physiol Biochem; 2018; 47(4):1465-1481. PubMed ID: 29949784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mir-20a-5p induced WTX deficiency promotes gastric cancer progressions through regulating PI3K/AKT signaling pathway.
    Li J; Ye D; Shen P; Liu X; Zhou P; Zhu G; Xu Y; Fu Y; Li X; Sun J; Xu J; Zhang Q
    J Exp Clin Cancer Res; 2020 Oct; 39(1):212. PubMed ID: 33032635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA3650 Promotes Gastric Cancer Proliferation and Migration through the PTEN/PI3K-AKT-mTOR and Hippo Pathways.
    Yang X; Wen J; He Q; Wang S; Ruan Q; Liao Q; He J; Fang S; Liu C; Tang H
    Protein Pept Lett; 2023; 30(11):966-973. PubMed ID: 38031771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-21 Inhibitors Modulate Biological Functions of Gastric Cancer Cells via PTEN/PI3K/mTOR Pathway.
    Wang P; Guan Q; Zhou D; Yu Z; Song Y; Qiu W
    DNA Cell Biol; 2018 Jan; 37(1):38-45. PubMed ID: 29185784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-28 promotes cell proliferation and invasion in gastric cancer via the PTEN/PI3K/AKT signalling pathway.
    Li L; Zhu X; Shou T; Yang L; Cheng X; Wang J; Deng L; Zheng Y
    Mol Med Rep; 2018 Mar; 17(3):4003-4010. PubMed ID: 29257342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-5590-3p inhibited tumor growth in gastric cancer by targeting DDX5/AKT/m-TOR pathway.
    Wu N; Han Y; Liu H; Jiang M; Chu Y; Cao J; Lin J; Liu Y; Xu B; Xie X
    Biochem Biophys Res Commun; 2018 Sep; 503(3):1491-1497. PubMed ID: 30029874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A miR-567-PIK3AP1-PI3K/AKT-c-Myc feedback loop regulates tumour growth and chemoresistance in gastric cancer.
    Zhang F; Li K; Yao X; Wang H; Li W; Wu J; Li M; Zhou R; Xu L; Zhao L
    EBioMedicine; 2019 Jun; 44():311-321. PubMed ID: 31078520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of Circular RNA ciRS-7 Abrogates the Tumor Suppressive Effect of miR-7 on Gastric Cancer via PTEN/PI3K/AKT Signaling Pathway.
    Pan H; Li T; Jiang Y; Pan C; Ding Y; Huang Z; Yu H; Kong D
    J Cell Biochem; 2018 Jan; 119(1):440-446. PubMed ID: 28608528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA HOTAIRM1 inhibits cell progression by regulating miR-17-5p/ PTEN axis in gastric cancer.
    Lu R; Zhao G; Yang Y; Jiang Z; Cai J; Zhang Z; Hu H
    J Cell Biochem; 2019 Apr; 120(4):4952-4965. PubMed ID: 30302796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of TRIM24 by miR-511 modulates cell proliferation in gastric cancer.
    Fang Z; Zhang L; Liao Q; Wang Y; Yu F; Feng M; Xiang X; Xiong J
    J Exp Clin Cancer Res; 2017 Jan; 36(1):17. PubMed ID: 28114950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOXD1-AS1 regulates FOXD1 translation and promotes gastric cancer progression and chemoresistance by activating the PI3K/AKT/mTOR pathway.
    Wu Q; Ma J; Wei J; Meng W; Wang Y; Shi M
    Mol Oncol; 2021 Jan; 15(1):299-316. PubMed ID: 32460412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA BX357664 inhibits gastric cancer progression by sponging miR-183a-3p to regulate the PTEN expression and PI3K/AKT pathway.
    Liang LC; Liu LQ; Liu L; Liu DL; He YR; Wan X; Zhu ZQ; Zhang BG; Liu SJ; Wu H; Hu L
    Food Chem Toxicol; 2021 Apr; 150():112069. PubMed ID: 33607219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-182 affects renal cancer cell proliferation, apoptosis, and invasion by regulating PI3K/AKT/mTOR signaling pathway.
    Fu JH; Yang S; Nan CJ; Zhou CC; Lu DQ; Li S; Mu HQ
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):351-357. PubMed ID: 29424922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.